PC model disentangles puzzle behind serious aggravation in individuals with COVID-19 Kumar Jeetendra | September 29, 2020 A study from the University of Pittsburgh School of Medicine and Cedars-Sinai addresses a mystery first raised in March: Why do some people with COVID-19 develop severe inflammation? The research shows how the molecular arrangement and arrangement of the SARS-CoV-2 spike protein–part of the virus that causes COVID-19–could be behind the inflammatory syndrome cropping up …
New SARS-CoV-2 IgM assay introduced by Beckman Coulter in countries accepting the CE Mark Kumar Jeetendra | November 12, 2020 Beckman Coulter, a medical diagnostics pioneer, today announced the launching of its accessibility SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The brand new IgM antibody test revealed 99.9% specificity with 1,400 negative trials and 100% sensitivity at >18 times post symptom onset and post positive PCR. Beckman Coulter’s IgM assay is …
NIAID sets up a clinical research organization to improve comprehension of child asthma Kumar Jeetendra | April 25, 2021 This nationwide network will conduct observational studies and clinical trials to improve understanding of asthma and develop prevention and treatment approaches tailored to children of low-income families residing in urban communities. NIAID plans to provide approximately $70 million over seven years to support the CAUSE network. This new initiative expands and extends NIAID’s long-standing attempts …
Understanding Thyroglobulin Antibody: What You Need to Know Kumar Jeetendra | March 14, 2024 TgAb targets thyroglobulin which is a protein that helps in the production of thyroid hormones and is manufactured by the immune system. The thyroid gland manufactures thyroglobulin which is important for metabolism control or regulation, growth or energy expenditure and also as a precursor for thyroxine (T4) along with triiodothyronine’s formation. On the opposite side, …
